In an experimental model of encephalomyelitis, oral treatment of curcumin reduced IL-17 levels along with IL-17 mRNA expression, production of transforming growth factor beta (TGF-β) and also suppressed signal transducer and activator of transcription 3 (STAT-3) expressions and STAT3-phosphorylation. This evidence concerns the gene IL17A and encephalomyelitis.